dipyridamole has been researched along with Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocardial lesions in subjects with CREST syndrome, may be a manifestation of focal ischemic injury resulting from functional vascular disease." | 1.29 | [Diagnostic role of the pharmacologic stress with dipyridamole in reduced coronary reserve associated with CREST syndrome. Description of 2 cases]. ( Bignotti, M; Giovannella, LC, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bignotti, M | 1 |
| Giovannella, LC | 1 |
1 other study available for dipyridamole and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia
| Article | Year |
|---|---|
[Diagnostic role of the pharmacologic stress with dipyridamole in reduced coronary reserve associated with CREST syndrome. Description of 2 cases].
Topics: Aged; CREST Syndrome; Dipyridamole; Exercise Test; Female; Humans; Middle Aged; Myocardial Ischemia | 1993 |